Inactive Instrument

IsoPlexis Corporation

ISO

US4650051067

Advanced Medical Equipment & Technology

IsoPlexis Corporation(NasdaqGS:ISO) dropped from Russell 2000 Growth Index

June 24, 2022 at 12:00 am EDT

Latest news about IsoPlexis Corporation

IsoPlexis Corporation(NasdaqGS:ISO) dropped from S&P TMI Index	23-03-22	CI
Berkeley Lights Closes IsoPlexis Merger; Combined Company PhenomeX to Begin Trading on Nasdaq Wednesday	23-03-21	MT
IsoPlexis Corporation(NasdaqGM:ISO) dropped from NASDAQ Composite Index	23-03-21	CI
Berkeley Lights, Inc. completed the acquisition of IsoPlexis Corporation from a group of shareholders.	23-03-20	CI
Transcript : IsoPlexis Corporation - Shareholder/Analyst Call	23-03-16
IsoPlexis Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-02	CI
IsoPlexis Corporation Auditor Raises 'Going Concern' Doubt	23-03-01	CI
IsoPlexis Reports Lower Preliminary 2022 Revenue; Shares Down After-Hours	23-01-12	MT
IsoPlexis Corporation Provides Preliminary Revenue Guidance for the Full Year Ended December 31, 2022	23-01-12	CI
Morgan Stanley Adjusts Price Target on IsoPlexis to $1.70 From $5, Maintains Equalweight Rating	23-01-05	MT
Sector Update: Healthcare Stocks Finish Narrowly LowerThursday	22-12-22	MT
Sector Update: Health Care Stocks Resisting Worst of Thursday Slide	22-12-22	MT
SVB Leerink Adjusts Price Target on IsoPlexis to $1.50 From $2, Maintains Market Perform Rating	22-12-22	MT
Top Premarket Gainers	22-12-22	MT
North American Morning Briefing : Stock Futures Lower as Activity Winds Down	22-12-22	DJ
Stocks to Watch : IsoPlexis, Lexicon Pharma, Micron Tech, Berkeley Lights	22-12-21	DJ
Transcript : Berkeley Lights, Inc., IsoPlexis Corporation - M&A Call	22-12-21
Berkeley Lights to Acquire IsoPlexis for $57.8 Million in Stock	22-12-21	MT
Berkeley Lights, Inc. announced a definitive agreement to acquire IsoPlexis Corporation from a group of shareholders for $56.3 million.	22-12-20	CI
SVB Securities Adjusts Price Target on IsoPlexis to $2.50 From $3, Maintains Market Perform Rating	22-11-11	MT
Transcript : IsoPlexis Corporation, Q3 2022 Earnings Call, Nov 10, 2022	22-11-10
Earnings Flash (ISO) ISOPLEXIS CORPORATION Reports Q3 Revenue $4.5M, vs. Street Est of $4.6M	22-11-10	MT
IsoPlexis Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
IsoPlexis Corporation Provides Revenue Guidance for the Year 2022	22-11-10	CI
IsoPlexis Corporation Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform	22-09-13	CI

IsoPlexis Corporation is a life sciences company. The Company is engaged in building solutions to develop curative medicines and personalized therapeutics. The Company's single-cell proteomics systems reveal biological activity in small subsets of cells, allowing researchers to connect directly to in-vivo biology and develop precise and personalized therapies. Its focuses on developing applications of its platform for cancer immunology and cell and gene therapy. The Company's platform is comprised of IsoLight and IsoSpark instruments, IsoCode and CodePlex chip consumables, and IsoSpeak software. Its IsoLight and IsoSpark instruments are designed to be automated benchtop proteomic hubs. Its IsoCode chips use its technology proteomic barcoding to capture single-cell protein information. Its CodePlex chips technology is used to test multiplexed bulk proteins. The Company's IsoSpeak software provides automated data analysis and accelerated insights with a push-button user interface.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+4.36%	32.18B
PRO MEDICUS LIMITED	+14.14%	7.33B
SECTRA AB	+22.93%	3.83B
EVOLENT HEALTH, INC.	-16.29%	3.23B
OMNICELL, INC.	-25.96%	1.25B
LUNIT INC.	-36.14%	1.12B
SIMULATIONS PLUS, INC.	-0.13%	912M
B-SOFT CO.,LTD.	-35.42%	859M
VERADIGM INC.	-24.12%	856M

Medical Software & Technology Services